WuXi Biologics
WuXi Biologics
Revolutionary Oral Biologics: Are They the Future?
Exploring oral biologics! 💊✨ They simplify treatment, improve compliance, but face challenges like stomach acid degradation. 🧬🌱 Solutions are emerging!
WuXi Biologics Revolutionizes Production with Major Breakthrough!
🔬 WuXi Biologics completes its first commercial PPQ campaign! 🌟 Achieving 70 cost reduction and 20 protein yield increase. 💰 Eco-friendly innovation! 🌱
Revolutionizing Therapies: Engineering Meets Biology!
**Excerpt:** 🌱 Discover how engineering meets biology to revolutionize cultured therapies! 🧪 Automation and AI are transforming biomanufacturing efficiency. 🔍⚙️
Unlocking Biopharma: WuXi’s PAT Revolution!
🌟 WuXi Biologics champions PAT in BioPharma, enhancing control and quality assurance for rapid therapy development! 📊🔬💡 BiotechInnovation
Candid and WuXi: $925 Million Cancer Breakthrough!
Candid Therapeutics partners with WuXi Biologics to advance trispecific T-cell engagers, aiming for $925 million in potential milestones! 💰🌍📰
Revolutionizing Cell Engineering with Transposase Technology!
🌱 ATUM innovates cell line engineering with transposase tools, enhancing genetic modifications in CHO cells for better biologics production! 🧬🌍
Unlocking Early Success: Choose the Best Biologics!
Unlock the secrets to identifying top biologic candidates early! 🚀 Enhance decision-making with innovative strategies and efficient evaluations. 🔍🧬📊
Revolutionary Guidelines Boost Biologics Testing Consistency!
🔬 New guidelines for 96-well plate chromatography enhance biologics screening! 🧪 Boost consistency and achieve reliable results across industries! 📈💻
Unlocking Biologics: Three Paths to Scale Production!
Biologics production can soar! 🚀 Explore scaling up, out, or down for optimal manufacturing flexibility and risk management. 📈🔄🔍💡
Lonza Boosts Microbial Production with Major Expansion!
🌍 Lonza expands its microbial manufacturing facility in Visp, Switzerland, adding two 4,000L fermenters and a new GMP license! ✅📈🔧
